Total planned funding: $144,072,142
Allocations
Countries/Regions
India | $144,072,142 |
Organizational Types
NGO | $54,210,170 |
Unknown | $41,437,036 |
Own Agency | $25,377,052 |
University | $14,432,112 |
Multi-lateral Agency | $2,860,000 |
Private Contractor | $2,589,272 |
FBO | $1,600,000 |
Host Country Government Agency | $939,200 |
Other USG Agency | $627,300 |
Implementing Agency | $0 |
Program Areas
Governance and Systems | $51,545,220 |
Prevention | $37,340,967 |
Care | $20,289,419 |
Management and Operations | $18,021,731 |
Testing | $8,727,636 |
Treatment | $8,147,169 |
Budget Codes
OHSS: Health Systems Strengthening | $28,171,303 |
HVOP: Sexual Prevention: Other Sexual Prevention | $21,325,438 |
HVSI: Strategic Information | $18,896,175 |
HVMS: Management and Operations | $18,021,731 |
HBHC: Care: Adult Care and Support | $12,428,057 |
HVCT: Testing: HIV Testing and Counseling | $8,727,636 |
HTXS: Treatment: Adult Treatment | $7,663,674 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $6,825,347 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $5,175,472 |
HLAB: Laboratory Infrastructure | $4,477,742 |
HKID: Care: Orphans and Vulnerable Children | $3,732,992 |
HVTB: Care: TB/HIV | $3,375,030 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $2,705,057 |
HMBL: Biomedical Prevention: Blood Safety | $1,299,653 |
PDCS: Care: Pediatric Care and Support | $753,340 |
PDTX: Treatment: Pediatric Treatment | $460,018 |
HTXD: Treatment: ARV Drugs | $23,477 |
HMIN: Biomedical Prevention: Injection Safety | $10,000 |
Top Partner Programs
Not Available:
$40,812,547
Countries/Regions
FHI 360:
$16,829,182
Countries/Regions
USG Aggregated Agencies:
$14,808,985
Countries/Regions
Voluntary Health Services:
$11,460,000
Countries/Regions